Joint modeling of multiple longitudinal patient-reported outcomes and survival.
Hatfield, Laura A
Joint modeling of multiple longitudinal patient-reported outcomes and survival. [electronic resource] - Journal of biopharmaceutical statistics Sep 2011 - 971-91 p. digital
Publication Type: Journal Article
1520-5711
10.1080/10543406.2011.590922 doi
Antimetabolites, Antineoplastic--therapeutic use
Bayes Theorem
Clinical Trials, Phase III as Topic--methods
Disease Progression
Disease-Free Survival
Glutamates--therapeutic use
Guanine--analogs & derivatives
Humans
Longitudinal Studies
Mesothelioma--drug therapy
Models, Statistical
Neoplasms--drug therapy
Pemetrexed
Research Design
Research Report
Self Report
Survival Analysis
Time Factors
Treatment Outcome
United States
United States Food and Drug Administration
Joint modeling of multiple longitudinal patient-reported outcomes and survival. [electronic resource] - Journal of biopharmaceutical statistics Sep 2011 - 971-91 p. digital
Publication Type: Journal Article
1520-5711
10.1080/10543406.2011.590922 doi
Antimetabolites, Antineoplastic--therapeutic use
Bayes Theorem
Clinical Trials, Phase III as Topic--methods
Disease Progression
Disease-Free Survival
Glutamates--therapeutic use
Guanine--analogs & derivatives
Humans
Longitudinal Studies
Mesothelioma--drug therapy
Models, Statistical
Neoplasms--drug therapy
Pemetrexed
Research Design
Research Report
Self Report
Survival Analysis
Time Factors
Treatment Outcome
United States
United States Food and Drug Administration